Optimi Health (OPTH)
Manufactures regulated psilocybin and MDMA products for therapeutic-access and clinical-research channels.
$5.01
vs last close+0.05 (+1.01%)
Something off on this page? Send us feedback.
EPSReportedEstimate
—————Feb '26Jun '26Aug '26
Reported—————−$0.35−$0.35−$0.40
Estimate—————−$0.19−$0.19−$0.26
Surprise—————−88.4%−89.3%−53.8%
RevenueReportedEstimate
—————Feb '26Jun '26Aug '26
Reported——————$71.3K$98.7K
Estimate—————$92.8K$92.8K$154.9K
Surprise——————−23.1%−36.3%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2027 | −$0.10 | — | — |
| Jun 2027 | −$0.11 | — | — |
| Mar 2027 | −$0.11 | — | — |
| Feb 2027 | −$0.13 | — | — |
| Sep 2026 | −$0.13 | — | — |
| Aug 2026 | −$0.26 | −$0.40 | −53.8% |
| Jun 2026 | −$0.19 | −$0.35 | −89.3% |
| Feb 2026 | −$0.19 | −$0.35 | −88.4% |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2027 | −$0.10 | — | — | $228.7K | — | — | — |
| Jun 2027 | −$0.11 | — | — | $214.4K | — | — | — |
| Mar 2027 | −$0.11 | — | — | $214.4K | — | — | — |
| Feb 2, 2027 | −$0.13 | — | — | $192.9K | — | — | — |
| Sep 2026 | −$0.13 | — | — | $193.0K | — | — | — |
| Aug 14, 2026 | −$0.26 | −$0.40 | −53.8% | $154.9K | $98.7K | −36.3% | −0.8% |
| Jun 1, 2026 | −$0.19 | −$0.35 | −89.3% | $92.8K | $71.3K | −23.1% | −5.5% |
| Feb 17, 2026 | −$0.19 | −$0.35 | −88.4% | $92.8K | — | — | −0.2% |